1. Home
  2. GDC vs HELP Comparison

GDC vs HELP Comparison

Compare GDC & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

HOLD

Current Price

$2.76

Market Cap

241.3M

Sector

Industrials

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.52

Market Cap

281.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDC
HELP
Founded
2015
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.3M
281.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GDC
HELP
Price
$2.76
$4.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$95.00
AVG Volume (30 Days)
35.5K
1.1M
Earning Date
05-14-2026
07-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.93
$4.41
52 Week High
$9.92
$8.55

Technical Indicators

Market Signals
Indicator
GDC
HELP
Relative Strength Index (RSI) 33.76 35.50
Support Level $2.32 $4.47
Resistance Level $3.72 $4.95
Average True Range (ATR) 0.28 0.34
MACD -0.11 -0.03
Stochastic Oscillator 14.97 7.19

Price Performance

Historical Comparison
GDC
HELP

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: